Use of recombinant factor VIIa (NovoSeven) in the treatment of a patient with type III von Willebrand’s disease and an inhibitor against von Willebrand factor - Ciavarella,N.; Schiavoni,M.; Valenzano,E. (Haemostasis, 1996)